Trials / Terminated
TerminatedNCT00051532
Seocalcitol Versus Placebo in Advanced Hepatocellular Carcinoma
Seocalcitol Versus Placebo in Advanced Hepatocellular Carcinoma. Efficacy of Seocalcitol (EB 1089) Enteric-Coated Capsules (5ug) or Placebo in the Treatment of Patients With Hepatocellular Carcinoma Not Amenable to Curative Treatment
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 700 (planned)
- Sponsor
- LEO Pharma · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to determine whether seocalcitol is effective in the treatment of advanced primary liver cancer (hepatocellular carcinoma \[HCC\]).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Seocalcitol |
Timeline
- Start date
- 1999-09-01
- Completion
- 2004-05-01
- First posted
- 2003-01-14
- Last updated
- 2025-02-25
Locations
5 sites across 5 countries: Canada, France, Italy, Spain, United Kingdom
Source: ClinicalTrials.gov record NCT00051532. Inclusion in this directory is not an endorsement.